Literature DB >> 6160440

Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration.

R L Levy, S Chiarillo.   

Abstract

This is a case report of hyperpyrexia, shock and death following initial injection of low-dose bleomycin (7.5 units) for a poorly differentiated metastatic carcinoma. Premedication with high-dose dexamethasone and acetaminophen did not abort the reaction. A review of the literature uncovered one nearly fatal reaction to a test dose of 1 unit of bleomycin All previously reported fatal cases were in patients with lymphoma who had received an initial dose of at least 25 units/m2. Since the 'safe' test dose of bleomycin is not known, test doses of 1 unit or lower should be routinely used; the effect of premedication is also unclear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160440     DOI: 10.1159/000225462

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

Review 1.  Mechanisms of bleomycin-induced lung damage.

Authors:  J Hay; S Shahzeidi; G Laurent
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.

Authors:  S Koldsland; J L Svennevig; G Lehne; E Johnson
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

3.  Lymphographic-Like Technique for the Treatment of Microcystic Lymphatic Malformation Components of <3 mm.

Authors:  V Da Ros; M Iacobucci; F Puccinelli; L Spelle; G Saliou
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-30       Impact factor: 3.825

4.  Fulminant hyperpyrexia induced by bleomycin.

Authors:  W H Leung; J Y Lau; T K Chan; C R Kumana
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

5.  A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.

Authors:  F Rosenfelt; J Palmer; I Weinstein; B Rosenbloom
Journal:  Yale J Biol Med       Date:  1982 Sep-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.